Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Stern

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2017
Vitamin D in the Parkinson Associated Risk Syndrome (PARS) studyMichelle E Fullard, Sharon X Xie, Ken Marek, et al.
Archives of Neurology|October 12, 2005
Multisite randomized trial of deep brain stimulationKenneth Follett, Frances Weaver, Matthew Stern, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2014
Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapyJohannes C Rothlind, Michele K York, Kim Carlson, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|December 2, 2021
Small-diameter artery decellularization: Effects of anionic detergent concentration and treatment duration on porcine internal thoracic arteriesColton Kostelnik, Julia Hohn, Carlos E Escoto-Diaz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's diseaseRay L Watts, Kelly E Lyons, Rajesh Pahwa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 2, 2006
Rasagiline improves quality of life in patients with early Parkinson's diseaseKevin M Biglan, Steven Schwid, Shirley Eberly, et al.
The Journal of Biological Chemistry|February 7, 2016
A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling PathwaysJianxin Hu, Matthew Stern, Luis E Gimenez, et al.
Neurorehabilitation|December 13, 2005
Falling risk factors in Parkinson's diseaseKeith Robinson, Andrew Dennison, David Roalf, et al.
Parkinsonism & Related Disorders|January 2, 2022
Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's diseaseJohannes C Rothlind, Michele K York, Ping Luo, et al.
Ebiomedicine|February 2, 2025
Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional studyKenneth Marek, David S Russell, Luis Concha-Marambio, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2017
Vitamin D in the Parkinson Associated Risk Syndrome (PARS) studyMichelle E Fullard, Sharon X Xie, Ken Marek, et al.
Archives of Neurology|October 12, 2005
Multisite randomized trial of deep brain stimulationKenneth Follett, Frances Weaver, Matthew Stern, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2014
Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapyJohannes C Rothlind, Michele K York, Kim Carlson, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|December 2, 2021
Small-diameter artery decellularization: Effects of anionic detergent concentration and treatment duration on porcine internal thoracic arteriesColton Kostelnik, Julia Hohn, Carlos E Escoto-Diaz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's diseaseRay L Watts, Kelly E Lyons, Rajesh Pahwa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 2, 2006
Rasagiline improves quality of life in patients with early Parkinson's diseaseKevin M Biglan, Steven Schwid, Shirley Eberly, et al.
The Journal of Biological Chemistry|February 7, 2016
A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling PathwaysJianxin Hu, Matthew Stern, Luis E Gimenez, et al.
Neurorehabilitation|December 13, 2005
Falling risk factors in Parkinson's diseaseKeith Robinson, Andrew Dennison, David Roalf, et al.
Parkinsonism & Related Disorders|January 2, 2022
Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's diseaseJohannes C Rothlind, Michele K York, Ping Luo, et al.
Ebiomedicine|February 2, 2025
Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional studyKenneth Marek, David S Russell, Luis Concha-Marambio, et al.
Pageof 6